Cancer Archives

Podcast 14 Feb 2025

Reversing cancer mechanisms to fight back against solid tumors

This week, we have a conversation with Catalym’s Eugen Leo about Visugromab is a monoclonal antibody that neutralizes the tumor-derived growth differentiation factor-15.

February 14, 2025

In Depth 4 Feb 2025

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025.

February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter

News and Trends 4 Feb 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach

February 4, 2025 - 6 minutesmins - By Jules Adam

Podcast 31 Jan 2025

Can tumor activated therapy kill solid tumors?

Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun

January 31, 2025

In Depth 29 Jan 2025

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat.

January 29, 2025 - 8 minutesmins - By Willow Shah-Neville

News and Trends 28 Jan 2025

ITM-11 succeeds in phase 3: The first big win for radiopharma?

Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.

January 28, 2025 - 9 minutesmins - By Jules Adam

In Depth 23 Jan 2025

mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics

In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases.

January 23, 2025 - 11 minutesmins - By Roohi Mariam Peter

In Depth 17 Jan 2025

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype?

January 17, 2025 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 16 Jan 2025

Ten first-in-class drugs on track for FDA approval in 2025

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025.

January 16, 2025 - 13 minutesmins - By Jules Adam

Best in Biotech 8 Jan 2025

Ten drugs to watch in 2025: will these therapies become blockbusters?

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate’s latest report.

January 8, 2025 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 Dec 2024

Six biotech companies leading the way in India

Discover six of the top biotech companies in India, which is currently brimming with biotechs and a young, skilled workforce.

December 30, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 25 Dec 2024

When biotech makes Christmas miracles a reality

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future.

December 25, 2024 - 8 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Reversing cancer mechanisms to fight back against solid tumors

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

Can tumor activated therapy kill solid tumors?

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

ITM-11 succeeds in phase 3: The first big win for radiopharma?

mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

Ten first-in-class drugs on track for FDA approval in 2025

Ten drugs to watch in 2025: will these therapies become blockbusters?

Six biotech companies leading the way in India

When biotech makes Christmas miracles a reality

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!